AVITA Medical (RCEL) Total Non-Current Liabilities (2018 - 2026)
AVITA Medical's (RCEL) quarterly Total Non-Current Liabilities came in at $71.8 million in Q4 2025, little changed YoY from $72.0 million in Q4 2024, and up 4.76% on a QoQ basis from $68.5 million in Q3 2025.
AVITA Medical (RCEL) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
AVITA Medical (RCEL) has 8 years of Total Non-Current Liabilities data on file, last reported at $71.8 million in Q4 2025.
- Quarterly Total Non-Current Liabilities changed 0.23% year-over-year to $71.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $71.8 million (changed 0.23% YoY) and the FY2025 annual result came in at $71.8 million, changed 0.23% from the prior year.
- Total Non-Current Liabilities grew to $71.8 million in Q4 2025, from $68.5 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $72.0 million in Q4 2024 to a low of $8.1 million in Q1 2022.
- A 5-year average of $41.6 million and a median of $59.3 million in 2023 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities slipped 11.18% — and 2023, when it jumped 405.49%.
- Tracing RCEL's Total Non-Current Liabilities over 5 years: stood at $11.3 million in 2021, then increased by 3.02% to $11.6 million in 2022, then jumped by 405.49% to $58.7 million in 2023, then climbed by 22.53% to $72.0 million in 2024, then retreated by 0.23% to $71.8 million in 2025.
- The last three Total Non-Current Liabilities figures came in at $71.8 million (Q4 2025), $68.5 million (Q3 2025), and $69.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 3.44 Bn |
| 10 | AVITA Medical | 311.80 Mn | 300.67 Mn | 17.77 Mn | 74.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 74.74 Mn |
| Dec 31, 2025 | 71.80 Mn |
| Sep 30, 2025 | 68.53 Mn |
| Jun 30, 2025 | 69.08 Mn |
| Mar 31, 2025 | 71.01 Mn |
| Dec 31, 2024 | 71.97 Mn |
| Sep 30, 2024 | 65.84 Mn |
| Jun 30, 2024 | 61.55 Mn |
| Mar 31, 2024 | 59.96 Mn |
| Dec 31, 2023 | 58.73 Mn |
| Dec 31, 2022 | 11.62 Mn |
| Jun 30, 2022 | 9.23 Mn |
| Mar 31, 2022 | 8.11 Mn |
| Dec 31, 2021 | 11.28 Mn |
| Sep 30, 2021 | 9.18 Mn |
| Jun 30, 2021 | 9.34 Mn |
| Mar 31, 2021 | 9.13 Mn |
| Jun 30, 2020 | 10.06 Mn |
| Jun 30, 2019 | 465,625.64 |
| Jun 30, 2018 | 101,698.83 |